Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025

Rhea-AI Summary

Rapid Micro Biosystems (Nasdaq: RPID), a life sciences technology company specializing in automation solutions for healthcare product manufacturing, has scheduled its first quarter 2025 financial results announcement for May 9, 2025, before market opening.

The company will host a webcast conference call at 8:30 a.m. ET on the same day, with management discussing the results. The webcast will be available on the company's website and archived for future reference.

LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2025 financial results prior to the market open on Friday, May 9, 2025.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, May 9, 2025. The live audio webcast will be accessible on the Company’s website and can be accessed with this link. The webcast will be archived and available for replay after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.

Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com

Media Contact:
media@rapidmicrobio.com

FAQ

When will Rapid Micro Biosystems (RPID) release Q1 2025 earnings?

Rapid Micro Biosystems will release Q1 2025 earnings before market open on Friday, May 9, 2025.

What time is RPID's Q1 2025 earnings conference call?

The earnings conference call is scheduled for 8:30 a.m. ET on Friday, May 9, 2025.

How can investors access RPID's Q1 2025 earnings call?

Investors can access the live audio webcast through the company's website. The webcast will also be archived for replay.

What does Rapid Micro Biosystems (RPID) specialize in?

Rapid Micro Biosystems provides mission-critical automation solutions for efficient manufacturing and fast, safe release of healthcare products.